Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-001239-42Phase 3Completed
Phase 3, randomised trial of ketoprofen in sprain and Joint contusion (2 arms), sponsored by APIGENEX s.r.o. Primary endpoint: number of patients cured without ADRs. Started Jun 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-001239-42.